Hyperfine, Inc. (HYPR)
0.8133
-0.02
(-2.83%)
USD |
NASDAQ |
Sep 04, 16:00
0.8299
+0.02
(+2.04%)
After-Hours: 20:00
Hyperfine Debt to Equity Ratio : 0.3649 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3649 |
| March 31, 2026 | 0.3891 |
| December 31, 2025 | 0.0077 |
| September 30, 2025 | 0.0068 |
| June 30, 2025 | 0.0071 |
| March 31, 2025 | 0.0065 |
| December 31, 2024 | 0.0055 |
| September 30, 2024 | 0.0019 |
| June 30, 2024 | 0.0024 |
| March 31, 2024 | 0.0025 |
| December 31, 2023 | 0.0022 |
| September 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0026 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 63.00M |
| Total Liabilities (Quarterly) | 26.24M |
| Shareholders Equity (Quarterly) | 36.76M |
| Current Ratio | 6.152 |
| Net Debt Paydown Yield | -1.83% |